trial
as of 2026-07-01Switching Antipsychotics: Abrupt Discontinuation Versus Overlap
NCTId NCT02640300
at a glance
Phase 4 · Completed
Enrollment 33 (actual)
Sponsored by Centre for Addiction and Mental Health
Primary completion 2004-07
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
33 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
1999-05
Primary completion
2004-07
Eligibility
ALL · 18 Years · 60 Years
Interventions & indications
Sponsors
Centre for Addiction and Mental HealthLead Sponsor
The Ian Douglas Bebensee FoundationCollaborator
Investigators
1
Gary Remington, MD PhD FRCPCPrincipal Investigator
Sites
1 total
Toronto, Canada
Facts & assertions
4 sourced
Enrollment
33
Phase
PHASE4
Primary Completion Date
2004-07
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
indication
investigator